title: Biologic matrices in oncologic breast reconstruction after mastectomy.
abstract: As the demand for post-mastectomy breast reconstruction has continued to rise, options for the implantable soft-tissue replacement products which enhance the aesthetic and reconstructive outcome of these procedures has grown as well. While the most common product used in an alloplastic breast reconstruction is an acellular dermal matrix derived from human sources, many other options are currently available, each offering their own unique properties and benefits. This review presents a concise description of each of the biologic matrices currently available and discusses their use in the context of one-stage and two-stage breast reconstructions.
authors.affiliation: Department of Plastic Surgery, The Ohio State University, 915 Olentangy River Road, Suite 2100, Columbus, OH 43212, USA.
authors.forename: Ergun
authors.initials: E
authors.lastname: Kocak
authors.forename: Theodore W
authors.initials: TW
authors.lastname: Nagel
authors.forename: John H
authors.initials: JH
authors.lastname: Hulsen
authors.forename: Katherine H
authors.initials: KH
authors.lastname: Carruthers
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Povoski
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Salgado
authors.forename: Albert H
authors.initials: AH
authors.lastname: Chao
mesh_terms: D018427:Breast Implants; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D016462:Mammaplasty / Q000009:adverse effects; D008408:Mastectomy; D011183:Postoperative Complications / Q000209:etiology; D054457:Tissue Scaffolds / Q000737:chemistry*